A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma

Cancer

Volumn 94, Issue 8, 2002, Pages 2217-2223

  Hareyama, Masato ^a   Sakata, Koh Ichi ^a   Shirato, Hiroki ^b   Nishioka, Takeshi ^b   Nishio, Masamichi ^c   Suzuki, Keishiro ^d   Saitoh, Akio ^e   Oouchi, Atsushi ^a   Fukuda, Satoshi ^b   Himi, Tetsuo ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HOKKAIDO CANCER CENTER   (Japan)

^d Obihiro Kosei Hospital   (Japan)

^e National Hospital Organization Hakodate Hospital   (Japan)

Author keywords

Cisplatin; Nasopharyngeal carcinoma; Neoadjuvant chemotherapy; Radiotherapy; Randomized trial

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; NEUTROPENIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STOMACH HEMORRHAGE; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT FAILURE; VOMITING;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHILD; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037089673     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10473     Document Type: Article

References (28)

1. Nasopharynx
2. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma
3. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma
4. Nasopharyngeal carcinoma: A review of cases treated by radiotherapy and chemotherapy
5. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma
6. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing CDDP and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
7. 3N2, MO) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival
8. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
9. Non-parametric estimates from incomplete observations
10. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy
11. Nasopharyngeal carcinoma: The Dana-Farber Cancer Institute experience with 24 patients treated with induction chemotherapy and radiotherapy
12. Neoadjuvant chemotherapy for advanced nasopharyngeal carcinoma
13. Sequential chemotherapy and radiation for nasopharyngeal cancer: Absence of long-term benefit despite a high rate of tumor response to chemotherapy
14. Computed tomography in nasopharyngeal carcinoma. Part I: T-stage conversion with CT-staging
15. Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: Correlated nucleic acid hybridization and histopathological examination
16. Carcinoma of the nasopharynx - The significance of histology
17. Nasopharyngeal carcinoma in childhood
18. Megavoltage irradiation of epithelial tumors of the nasopharynx
19. A review of neoadjuvant chemotherapy for head and neck cancer: Partially shrunken tumors may be both leaner and meaner
20. The hazard of accelerated tumor clonogen repopulation during radiotherapy
21. Docetaxel: An active drug for squamous cell carcinoma of the head and neck
22. Final report of a Phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group trial (PA390)
23. Preclinical profile of docetaxel (taxotere): Efficacy as a single agent and in combination
24. Multicenter Phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck
25. Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck
26. Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma
27. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: A radiation therapy oncology group study
28. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099